The primary objective of the Training Program in Hematology, which will complete its 30th year of funding in 2014, is to train MD, MD/PhD, and PhD postdoctoral fellows interested in adult hematology for careers in academic medicine and biomedical research. Johns Hopkins hematology fellows, the major substrate for this T32, rotate on benign and malignant hematology services but do not rotate on any solid tumor rotations. Thus, the purpose of the proposed training program is to prepare qualified individuals with an MD and/or PhD degree for a research career in the field of adult hematology. The training program consists of well-funded and highly experienced investigators, most of who are internationally recognized for their research pertaining to hematopoiesis and stem cell biology, anemias, vascular biology, bone marrow failure states and myeloproliferative diseases. Training is enhanced by an outstanding research environment with state-of-the-art research facilities, outstanding faculty mentors, and existing program project grants on bone marrow transplantation and stem cell biology. Despite a national trend away from single board hematology fellowship programs, Johns Hopkins continues to attract outstanding MD and MD/PhD candidate for single board hematology training and prepares them for careers in biomedical research.
Specific aims are of this training program are: 1) to provide research training opportunities in a variety of areas pertaining to hematology including benign and malignant hematopoiesis, bone marrow failure disorders, bone marrow transplantation, stem cell biology, immunology, genetics, vascular biology, and myeloproliferative/myelodysplastic syndromes 2) to provide the opportunity for structured coursework and seminars pertaining to clinical, translational and basic research pertaining to hematology, and to provide opportunities for instruction in grant writing, manuscript writing, public speaking and biostatistics 3) to allo for group mentoring and careful monitoring of the trainees'progress and the overall success of the training program 4) to address the critical shortage of adult hematologists in pursuing careers in academic hematology

Public Health Relevance

The goal of this Program is to attract and to train exceptional postdoctoral fellows for careers in academic adult hematology. Improved understanding of the underpinnings of stem cell biology, anemias, vascular biology, bone marrow failure states, and myeloproliferative diseases will aid in translating laboratory findings into novel clinical therapies.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Tanno, Toshihiko; Lim, Yiting; Wang, Qiuju et al. (2014) Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood 123:725-33
Kanakry, Jennifer A; Kasamon, Yvette L; Bolanos-Meade, Javier et al. (2013) Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 19:1514-7
Hubbi, Maimon E; Kshitiz; Gilkes, Daniele M et al. (2013) A nontranscriptional role for HIF-1* as a direct inhibitor of DNA replication. Sci Signal 6:ra10
Kanakry, Christopher G; Ganguly, Sudipto; Zahurak, Marianna et al. (2013) Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide. Sci Transl Med 5:211ra157
Ghiaur, Gabriel; Yegnasubramanian, Srinivasan; Perkins, Brandy et al. (2013) Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling. Proc Natl Acad Sci U S A 110:16121-6
Yuan, Xuan; Braunstein, Evan M; Ye, Zhaohui et al. (2013) Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells. Stem Cells Transl Med 2:819-29
Hubbi, Maimon E; Hu, Hongxia; Kshitiz et al. (2013) Sirtuin-7 inhibits the activity of hypoxia-inducible factors. J Biol Chem 288:20768-75
Ghiaur, Gabriel; Gerber, Jonathan; Jones, Richard J (2012) Concise review: Cancer stem cells and minimal residual disease. Stem Cells 30:89-93
Ghiaur, Gabriel; Gerber, Jonathan M; Matsui, William et al. (2012) Cancer stem cells: relevance to clinical transplantation. Curr Opin Oncol 24:170-5
Hubbi, Maimon E; Gilkes, Daniele M; Baek, Jin H et al. (2012) Four-and-a-half LIM domain proteins inhibit transactivation by hypoxia-inducible factor 1. J Biol Chem 287:6139-49

Showing the most recent 10 out of 62 publications